Not applicableStudy completedNCT02250755What this trial is testingMRI Perfusion on T1 and T2 Brain Lesion(s)Who this might be right forLung Carcinoma Metastatic to the Brain University Hospital, Lille 30
Early research (Phase 1)Ended earlyNCT05831995What this trial is testingSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.Who this might be right forAdvanced Solid TumorRAS MutationRAF Mutation+1 more ABM Therapeutics Corporation 12
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Large-scale testing (Phase 3)Study completedNCT00377156What this trial is testingStereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesWho this might be right forBreast CancerCognitive/Functional EffectsLung Cancer+2 more Alliance for Clinical Trials in Oncology 213
Testing effectiveness (Phase 2)Ended earlyNCT04789668What this trial is testingBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more M.D. Anderson Cancer Center 8
Early research (Phase 1)Study completedNCT04430842What this trial is testingDose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SWho this might be right forAstrocytomaBrain CancerBrain Metastases+20 more Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267What this trial is testingBasket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)Who this might be right forBreast CancerCholangiocarcinomaColorectal Cancer+13 more Hoffmann-La Roche 534
Early research (Phase 1)Looking for participantsNCT05538130What this trial is testingLearn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsWho this might be right forMelanomaGliomaThyroid Cancer+10 more Pfizer 124
Not applicableUnknownNCT03424980What this trial is testingEvaluate Effectiveness and Safety of Tyrosine Kinase InhibitorsWho this might be right forNon-small Cell Lung Cancer Metastatic Tang-Du Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02308020What this trial is testingAbemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainWho this might be right forBreast CancerNon-small Cell Lung CancerMelanoma+1 more Eli Lilly and Company 162
Not applicableEnded earlyNCT03488472What this trial is testingRadiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the BrainWho this might be right forBrain MetastasesSmall Cell Lung Cancer Drexell Hunter Boggs 1
Testing effectiveness (Phase 2)Ended earlyNCT00550654What this trial is testingConformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+3 more National Institutes of Health Clinical Center (CC) 1
Large-scale testing (Phase 3)Looking for participantsNCT04804644What this trial is testingTesting if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityWho this might be right forMetastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainRecurrent Lung Small Cell Carcinoma+1 more NRG Oncology 200
Testing effectiveness (Phase 2)Study completedNCT03046992What this trial is testingClinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLCWho this might be right forEGFR Gene Mutation Yuhan Corporation 224
Early research (Phase 1)Study completedNCT04631029What this trial is testingTesting the Addition of an Anti-cancer Drug, Entinostat, to the Usual Chemotherapy and Immunotherapy Treatment (Atezolizumab, Carboplatin and Etoposide) for Previously Untreated Aggressive Lung Cancer That Has SpreadWho this might be right forExtensive Stage Lung Small Cell CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT02696993What this trial is testingNivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung CancerWho this might be right forMetastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7 M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT02978404What this trial is testingCombining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesWho this might be right forClear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083687What this trial is testingLorlatinib in ROS1+ NSCLC With Brain MetastasisWho this might be right forLung Cancer (NSCLC) Hunan Cancer Hospital 21
Testing effectiveness (Phase 2)WithdrawnNCT05840770What this trial is testingCemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung CancerWho this might be right forMetastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainStage IV Lung Cancer AJCC v8 City of Hope Medical Center